(0.05%) 5 471.97 points
(0.06%) 39 138 points
(0.29%) 17 768 points
(-0.22%) $80.65
(-5.04%) $2.62
(-0.89%) $2 310.10
(-0.37%) $28.76
(3.07%) $1 016.70
(0.34%) $0.936
(0.74%) $10.68
(0.50%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors...
Stats | |
---|---|
Dagens volum | 18 141 |
Gjennomsnittsvolum | 45 500 |
Markedsverdi | 11.08M |
EPS | $-0.110 ( Q1 | 2024-05-15 ) |
Neste inntjeningsdato | ( $0 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0200 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0140 (2.02%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-06 | Weis Holger | Buy | 19 200 | Employee Stock Option (right to buy) |
2024-06-06 | Weis Holger | Buy | 4 524 | Employee Stock Option (right to buy) |
2024-06-06 | Vieser Jaime | Buy | 12 800 | Employee Stock Option (right to buy) |
2024-06-06 | Postma Robert W | Buy | 12 800 | Employee Stock Option (right to buy) |
2024-06-06 | Hofmeister Robert | Buy | 12 800 | Employee Stock Option (right to buy) |
INSIDER POWER |
---|
96.63 |
Last 87 transactions |
Buy: 15 616 124 | Sell: 1 296 896 |
Alaunos Therapeutics, Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
OMEX | 0.832 |
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Alaunos Therapeutics, Økonomi
Annual | 2023 |
Omsetning: | $5 000.00 |
Bruttogevinst: | $-2.31M (-46 200.00 %) |
EPS: | $-2.20 |
FY | 2023 |
Omsetning: | $5 000.00 |
Bruttogevinst: | $-2.31M (-46 200.00 %) |
EPS: | $-2.20 |
FY | 2022 |
Omsetning: | $2.92M |
Bruttogevinst: | $163 000 (5.58 %) |
EPS: | $-2.60 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-0.370 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Alaunos Therapeutics,
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and development agreement with the National Cancer Institute. The company was formerly known as ZIOPHARM Oncology, Inc. and changed its name to Alaunos Therapeutics, Inc. in January 2022. Alaunos Therapeutics, Inc. is headquartered in Houston, Texas.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.